SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

American Equity Investment Life Holding Co – ‘10-Q’ for 6/30/19 – ‘EX-32.1’

On:  Thursday, 8/8/19, at 3:22pm ET   ·   For:  6/30/19   ·   Accession #:  1039828-19-56   ·   File #:  1-31911

Previous ‘10-Q’:  ‘10-Q’ on 5/8/19 for 3/31/19   ·   Next:  ‘10-Q’ on 11/8/19 for 9/30/19   ·   Latest:  ‘10-Q’ on 11/8/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/08/19  American Equity Inv Life Hold… Co 10-Q        6/30/19   74:13M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.87M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
12: R1          Cover Page                                          HTML     77K 
13: R2          Consolidated Balance Sheets                         HTML    114K 
14: R3          Consolidated Balance Sheets (Parentheticals)        HTML     48K 
15: R4          Consolidated Statements of Operations               HTML    105K 
16: R5          Consolidated Statements of Comprehensive Income     HTML     54K 
                (Loss)                                                           
17: R6          Consolidated Statements of Changes in               HTML     58K 
                Stockholders' Equity                                             
18: R7          Consolidated Statements of Changes in               HTML     28K 
                Stockholders' Equity (Parentheticals)                            
19: R8          Consolidated Statements of Cash Flows               HTML    158K 
20: R9          Significant Accounting Policies                     HTML     33K 
21: R10         Fair Values of Financial Instruments                HTML    250K 
22: R11         Investments                                         HTML    505K 
23: R12         Mortgage Loans on Real Estate                       HTML    234K 
24: R13         Derivative Instruments                              HTML    180K 
25: R14         Notes Payable and Amounts Due Under Repurchase      HTML     40K 
                Agreements                                                       
26: R15         Commitments and Contingencies                       HTML     28K 
27: R16         Earnings (Loss) Per Share                           HTML     60K 
28: R17         Significant Accounting Policies (Policies)          HTML     87K 
29: R18         Fair Values of Financial Instruments (Tables)       HTML    228K 
30: R19         Investments (Tables)                                HTML    505K 
31: R20         Mortgage Loans on Real Estate (Tables)              HTML    227K 
32: R21         Derivative Instruments (Tables)                     HTML    185K 
33: R22         Notes Payable and Amounts Due Under Repurchase      HTML     39K 
                Agreements (Tables)                                              
34: R23         Earnings (Loss) Per Share (Tables)                  HTML     60K 
35: R24         Significant Accounting Policies (Narrative)         HTML     27K 
                (Details)                                                        
36: R25         Fair Values of Financial Instruments (Narrative)    HTML     58K 
                (Details)                                                        
37: R26         Fair Values of Financial Instruments (Fair Values   HTML     79K 
                and Carrying Amounts of Financial Instruments)                   
                (Details)                                                        
38: R27         Fair Values of Financial Instruments (Assets and    HTML    123K 
                Liabilities Measured on a Recurring Basis by Fair                
                Value Hierarchy) (Details)                                       
39: R28         Fair Values of Financial Instruments (Assumptions   HTML     64K 
                Used in Estimating Fair Value) (Details)                         
40: R29         Fair Values of Financial Instruments                HTML     40K 
                (Reconciliation of Beginning and Ending Balances                 
                of Level 3 Liabilities) (Details)                                
41: R30         Investments (Narrative) (Details)                   HTML     37K 
42: R31         Investments (Schedule of Fixed Maturity             HTML     61K 
                Securities) (Details)                                            
43: R32         Investments (Fixed Maturity Securities by           HTML     82K 
                Contractual Maturity) (Details)                                  
44: R33         Investments (Net Unrealized Gains (Losses) on       HTML     36K 
                Available for Sale Fixed Maturity Securities                     
                Reported as a Separate Component of Stockholders'                
                Equity) (Details)                                                
45: R34         Investments (Credit Quality of Fixed Maturity       HTML     44K 
                Security Portfolio by NAIC Designation) (Details)                
46: R35         Investments (Gross Unrealized Losses on             HTML     97K 
                Investments, By Category and Length of Time)                     
                (Details)                                                        
47: R36         Investments (Changes in Net Unrealized              HTML     43K 
                Gains/Losses on Investments) (Details)                           
48: R37         Investments (Net Realized Gains (Losses) on         HTML     56K 
                Invesments, Excluding Other Than Temporary                       
                Impairments) (Details)                                           
49: R38         Investments (Other Than Temporary Impairments by    HTML     52K 
                Asset Type) (Details)                                            
50: R39         Investments (Cumulative Credit Loss Portion of      HTML     36K 
                Other Than Temporary Impairment Recognized in                    
                Operations) (Details)                                            
51: R40         Investments (Cumulative Noncredit Portion of Other  HTML     45K 
                Than Temporary Impairment Recognized in Other                    
                Comprehensive Income and Change in Fair Value                    
                Since Other Than Temporary Impairment) (Details)                 
52: R41         Mortgage Loans on Real Estate (Narrative)           HTML     52K 
                (Details)                                                        
53: R42         Mortgage Loans on Real Estate (Summary of Mortgage  HTML     34K 
                Loan Portfolio) (Details)                                        
54: R43         Mortgage Loans on Real Estate (Mortgage Loan        HTML     65K 
                Portfolio Summarized by Geographic Region and                    
                Property Type) (Details)                                         
55: R44         Mortgage Loans on Real Estate (Allowance for Loan   HTML     42K 
                Losses Rollforward) (Details)                                    
56: R45         Mortgage Loans on Real Estate (Impaired Mortgage    HTML     30K 
                Loans on Real Estate By Basis of Impairment)                     
                (Details)                                                        
57: R46         Mortgage Loans on Real Estate (Mortgage Loans by    HTML     31K 
                Credit Quality Indicator) (Details)                              
58: R47         Mortgage Loans on Real Estate (Schedule of          HTML     39K 
                Financing Receivables Past Due) (Details)                        
59: R48         Mortgage Loans on Real Estate (Schedule of          HTML     59K 
                Impaired Financing Receivables) (Details)                        
60: R49         Derivative Instruments (Narrative) (Details)        HTML     39K 
61: R50         Derivative Instruments (Fair Value of Derivative    HTML     42K 
                Instruments as Presented in the Consolidated                     
                Balance Sheets) (Details)                                        
62: R51         Derivative Instruments (Change in Fair Value of     HTML     42K 
                Derivatives Included in the Consolidated Statement               
                of Operations) (Details)                                         
63: R52         Derivative Instruments (Derivative Call Options,    HTML     60K 
                Notional Amount and Fair Value, by Counterparty)                 
                (Details)                                                        
64: R53         Derivative Instruments (Interest Rate Swap)         HTML     38K 
                (Details)                                                        
65: R54         Derivative Instruments (Interest Rate Caps)         HTML     40K 
                (Details)                                                        
66: R55         Notes Payable and Amounts Due Under Repurchase      HTML     37K 
                Agreements (Schedule of Notes Payable) (Details)                 
67: R56         Notes Payable and Amounts Due Under Repurchase      HTML     35K 
                Agreements (2027 Notes Narrative) (Details)                      
68: R57         Notes Payable and Amounts Due Under Repurchase      HTML     29K 
                Agreements (Repurchase Agreements Narrative)                     
                (Details)                                                        
69: R58         Commitments and Contingencies (Narrative)           HTML     28K 
                (Details)                                                        
70: R59         Earnings (Loss) Per Share (Schedule of Earnings     HTML     58K 
                (Loss) Per Share, Basic and Diluted) (Details)                   
72: XML         IDEA XML File -- Filing Summary                      XML    143K 
11: XML         XBRL Instance -- a2019-06x30ael10q_htm               XML   4.17M 
71: EXCEL       IDEA Workbook of Financial Reports                  XLSX     99K 
 7: EX-101.CAL  XBRL Calculations -- ael-20190630_cal                XML    271K 
 8: EX-101.DEF  XBRL Definitions -- ael-20190630_def                 XML    843K 
 9: EX-101.LAB  XBRL Labels -- ael-20190630_lab                      XML   1.71M 
10: EX-101.PRE  XBRL Presentations -- ael-20190630_pre               XML   1.04M 
 6: EX-101.SCH  XBRL Schema -- ael-20190630                          XSD    169K 
73: JSON        XBRL Instance as JSON Data -- MetaLinks              359±   580K 
74: ZIP         XBRL Zipped Folder -- 0001039828-19-000056-xbrl      Zip    346K 


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of American Equity Investment Life Holding Company (the "Company") on Form 10-Q for the period ended June 30, 2019 as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), I, John M. Matovina, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:
By:
 
 
 
 
 
John M. Matovina, Chief Executive Officer and President
(Principal Executive Officer)



Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/8/19None on these Dates
For Period end:6/30/19
 List all Filings 
Top
Filing Submission 0001039828-19-000056   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 5:51:31.1pm ET